Medicare Part D Prior Authorization Guidelines 2027: What Every Your Practice Should Know About Precertification and Payer Compliance

Understand Medicare Part D authorization requirements, including prescription drug coverage criteria, step therapy, quantity limits, clinical evidence, and exceptions….

Table of Contents

A Medicare patient arrives at the pharmacy with a valid prescription, but the pharmacist cannot dispense it under the patient’s drug coverage. The prescription itself is not necessarily the problem.

Medicare Part D prior authorization is also different from prior authorization for a procedure, imaging study or other medical service.

That distinction should guide the entire workflow.

1. First Understand How Medicare Part D Drug Coverage Works

2. What Medicare Part D Prior Authorization Actually Means

3. Medicare Part D Prior Authorization vs. Medical Prior Authorization

4. Start With the Patient’s Actual Part D Plan

5. Step One: Determine Which Benefit Covers the Drug

6. Step Two: Check the Part D Formulary

7. Three Major Part D Utilization-Management Controls

8. Prior Authorization and Formulary Exceptions Are Related—but Different

9. When a Prior Authorization Exception May Be Appropriate

10. The Prescriber’s Supporting Statement Can Start the Decision Clock

11. What Should Be Included in a Strong Part D PA Request?

12. Build the Request Around the Drug’s Coverage Criteria

13. Document Previous Medication Trials Properly

14. Standard Medicare Part D Coverage Determination

15. Expedited Medicare Part D Coverage Determination

16. Standard vs. Expedited Part D Decision Timeframes

17. Do Not Confuse the 24-Hour Rule With the Wrong PA Process

18. Medicare Part D Transition Fills

19. A Transition Fill Is Not the Final Solution

20. Protected Drug Classes Still Require Careful Verification

21. When Step Therapy Creates the Problem

22. When a Quantity Limit Creates the Problem

23. Formulary Exception for a Non-Formulary Drug

24. Tiering Exceptions

25. What Happens at the Pharmacy Counter?

26. A Better Pharmacy Rejection Workflow

27. What Happens When Part D Prior Authorization Is Approved?

28. What Happens When the Request Is Denied?

29. Level 1: Redetermination by the Part D Plan

30. Part D Coverage Determination vs. Redetermination

31. Higher Levels of Medicare Part D Appeal

32. Prescribers Have an Important Role in Part D Appeals

33. Common Reasons Medicare Part D PA Requests Fail

34. Medicare Part D Prior Authorization Tracking Fields

35. Build a Part D Authorization Work Queue by Deadline

36. Part D Prior Authorization KPIs

37. A Practical Medicare Part D PA Workflow

38. Before the Next Refill, Check the Authorization Again

39. Preparing for Electronic Medicare Part D Prior Authorization

40. Medicare Part D Pre-Submission Checklist

41. Frequently Asked Questions About Medicare Part D Prior Authorization

42. Final Thoughts

First Understand How Medicare Part D Drug Coverage Works

Medicare Part D provides prescription-drug coverage through Medicare-approved private plans. A beneficiary may receive Part D coverage through a stand-alone Medicare Prescription Drug Plan or through a Medicare Advantage plan that includes prescription-drug coverage.  Each Part D plan has a drug list called a formulary.

The formulary determines which prescription drugs the plan covers and can organize medications into different cost-sharing tiers. But appearing on the formulary does not automatically mean the patient can fill the prescription without additional review. A formulary medication can still be subject to:

Prior authorization

Step therapy

Quantity limits

or another applicable utilization-management requirement. This is why formulary verification should include more than a simple covered/not-covered check.

What Medicare Part D Prior Authorization Actually Means

Prior authorization means the Part D plan requires approval based on its specific requirements before it will cover certain medications. The prescriber may need to demonstrate that:

  • The medication is medically necessary
  • The patient’s diagnosis meets applicable criteria
  • Required alternatives have been tried when applicable
  • Previous treatment was ineffective
  • Previous treatment caused adverse effects
  • Alternative therapy is contraindicated
  • Requested dosing is clinically appropriate
  • Other plan-specific coverage requirements have been satisfied

Medicare Part D Prior Authorization vs. Medical Prior Authorization

This distinction is essential for provider offices.

Medicare Part DMedical Prior Authorization
Primarily prescription-drug coverageProcedures, services and medical items
Managed through the patient’s Part D planOften processed under medical benefits
Drug formulary is centralMedical coverage policy is central
May involve pharmacy claimsUsually involves medical claims
Uses drug-specific UM requirementsUses service/procedure-specific requirements
Can involve formulary exceptionsUsually does not use Part D formulary exceptions
Prescriber supporting statement may be requiredClinical records commonly support medical necessity

Start With the Patient’s Actual Part D Plan

There is no single nationwide prior-authorization list that applies identically to every Medicare Part D enrollee. Providers should identify:

  • Patient name
  • Medicare information
  • Part D plan
  • Member ID
  • RxBIN
  • RxPCN
  • RxGroup when applicable
  • Effective coverage date
  • Prescribing provider
  • Dispensing pharmacy
  • Requested medication

Step One: Determine Which Benefit Covers the Drug

Before starting a Part D authorization, verify that the medication is actually being processed under Part D.

Some medications may instead fall under Medicare Part B depending on the drug, how it is administered, where it is administered and the circumstances of treatment. A practical first check is:

Medication → Administration → Setting → Benefit → Coverage pathway

For example, a self-administered outpatient prescription may commonly be handled through Part D, while certain drugs furnished and administered in a physician’s office or other qualifying circumstances may fall under Part B. Misidentifying the benefit can send the authorization to the wrong place before the clinical review even begins.

Step Two: Check the Part D Formulary

Once Part D responsibility has been established, review the patient’s current formulary.

Determine:

Is the drug listed?

If yes:

What tier is it on?

Then:

Does it carry a utilization-management restriction?

A complete formulary check should capture:

FieldWhat to Verify
DrugExact medication
FormTablet, capsule, injection, etc.
StrengthPrescribed strength
Formulary statusCovered/non-formulary
TierApplicable formulary tier
Prior authorizationYes/No
Step therapyYes/No
Quantity limitApplicable limit
Specialty requirementsIf applicable
Alternative drugsPreferred options when listed

Three Major Part D Utilization-Management Controls

Medicare drug plans can apply several coverage rules. Understanding the difference between them prevents unnecessary submissions.

Prior Authorization

The plan requires approval before covering the medication. The prescriber may need to demonstrate that the patient satisfies drug-specific criteria.

Step Therapy

The patient may be required to try another covered medication before the plan covers the requested drug.

The required first-line medication may be a generic, biosimilar or another preferred treatment considered appropriate for the condition.

Quantity Limit

The plan limits how much medication it will cover during a particular period. For example, the plan might cover a certain number of tablets every 30 days. If the patient’s medically necessary dosage exceeds that limit, an exception may be needed. These controls should be documented separately because the response to each one can be different.

Prior Authorization and Formulary Exceptions Are Related—but Different

This is one of the most important concepts in Part D. A coverage determination is the Part D plan’s decision about prescription-drug coverage. An exception request is a particular type of coverage determination. A formulary exception can be requested when the patient needs:

  • A Part D drug that is not on the plan’s formulary
  • A waiver of a prior-authorization requirement
  • A waiver of a step-therapy requirement
  • A waiver of a quantity limit

A tiering exception is different. It generally asks the plan to cover a non-preferred formulary drug at the cost-sharing terms associated with a preferred tier when the applicable Medicare requirements are satisfied. Knowing which request you are making is important because the supporting clinical argument will differ.

What Should You Includ in a Strong Part D PA Request?

The exact requirements vary by medication and plan, but a complete clinical submission may include:

Patient Information

  • Patient name
  • Date of birth
  • Member ID
  • Part D plan
  • Relevant contact information

Prescription Information

  • Drug name
  • Strength
  • Dosage form
  • Dose
  • Frequency
  • Quantity
  • Days’ supply
  • Route when applicable

Clinical Information

  • Diagnosis
  • ICD-10-CM code
  • Relevant symptoms
  • Disease severity
  • Treatment history
  • Previous medications
  • Treatment response
  • Adverse reactions
  • Contraindications
  • Laboratory findings when applicable
  • Relevant test results
  • Clinical rationale

Prescriber Information

  • Prescriber name
  • NPI
  • Specialty
  • Office contact information
  • Appropriate clinical contact

The objective is to answer the plan’s clinical criteria clearly rather than submitting an unfocused medical record.

You Build the Request Around the Drug’s Coverage Criteria

A strong Part D authorization should read like a direct response to the plan’s requirements. Imagine the criteria require:

  1. Confirmed diagnosis
  2. Previous trial of Drug A
  3. Inadequate response to Drug A
  4. No contraindication to the requested therapy
  5. Dose within the permitted range

Your submission should make each point easy to locate.

For example:

Diagnosis: Documented condition and supporting findings.

Previous treatment: Drug A used from [date] to [date].

Response: Symptoms remained inadequately controlled.

Safety: No identified contraindication to requested therapy.

Dose: Requested regimen is clinically appropriate.

Standard Medicare Part D Coverage Determination

For a standard request for a drug benefit that does not involve an exception, the Part D plan generally must provide its decision within 72 hours after receiving the request. The enrollee, prescriber or enrollee’s representative may request the coverage determination. Requests for benefits can generally be made verbally or in writing. A practice should record:

Submission date/time → Request type → Confirmation/reference number → Expected deadline → Current status → Decision

Expedited Medicare Part D Coverage Determination

Some medication requests cannot safely wait for the standard timeframe. An expedited coverage determination can be requested when applying the standard timeframe could seriously jeopardize the enrollee’s life or health or ability to regain maximum function under the applicable Medicare standard.

When the expedited request is accepted, the Part D plan generally must make the decision within 24 hours for a benefit request. Practices should not mark every urgent office request as expedited automatically. The request should reflect the patient’s clinical circumstances and the applicable Medicare standard.

Standard vs. Expedited Part D Decision Timeframes

RequestGeneral CMS Decision Timeframe
Standard benefit coverage determination72 hours
Expedited benefit coverage determination24 hours
Standard exception request72 hours after supporting statement is received
Expedited exception request24 hours after supporting statement is received
Payment request14 calendar days

These are federal Part D coverage-determination timeframes, not the medical-service PA timeframes sometimes encountered under other insurance programs.

Protected Drug Classes Still Require Careful Verification

Medicare Part D plans must provide broad formulary coverage for drugs in certain protected classes. These include medications used for:

  • Cancer
  • HIV/AIDS
  • Depression
  • Psychotic disorders
  • Seizure disorders
  • Immunosuppression following organ transplantation

However, protected-class status should not be interpreted as meaning that every prescription is automatically free of all utilization-management requirements under every circumstance. Providers should still review the patient’s actual formulary and applicable coverage rules.

When Step Therapy Creates the Problem

A pharmacy rejection may indicate that the patient needs to try another medication first.

Before changing therapy automatically, review the patient’s history, you need to ask:

Has the required drug already been tried?

Was it ineffective?

Did the patient experience adverse effects?

Is it contraindicated?

Would using it create a clinically meaningful risk?

When a Quantity Limit Creates the Problem

Quantity limits can create a different type of pharmacy rejection. Suppose the plan covers:

30 tablets every 30 days

but the patient’s medically necessary regimen requires:

60 tablets every 30 days.

The problem may not be the drug itself. The problem may be the quantity. An exception request can be considered when the prescriber believes the plan’s quantity restriction is not medically appropriate for the patient. Documentation should explain:

  • Diagnosis
  • Prescribed dose
  • Why the dose is necessary
  • Why the standard quantity is insufficient
  • Relevant clinical evidence
  • Treatment response when applicable

What Happens When Your Part D Prior Authorization is Approved?

Approval should trigger verification, and check:

Approval ElementCompare With Prescription
PatientCorrect beneficiary
DrugCorrect medication
StrengthPrescribed strength
DoseIntended regimen
QuantityRequested amount
Authorization periodCurrent prescription period
IndicationCorrect diagnosis/use
Pharmacy benefitCorrect Part D plan

What Happens When Your Request is Denied?

An unfavorable Part D coverage determination should not end with:

“Insurance denied the medication.”

You need to read the decision.

Identify exactly why coverage was denied.

The plan’s adverse coverage determination provides information about appeal rights.

Possible next steps may include:

  • Supplying missing clinical information where appropriate
  • Reviewing whether the request was submitted correctly
  • Considering an appropriate formulary alternative
  • Requesting a redetermination
  • Pursuing an expedited appeal when applicable
  • Moving to subsequent levels of the Medicare Part D appeals process if necessary

Level 1: Redetermination by the Part D Plan

The first appeal level after an unfavorable coverage determination is generally a redetermination by the Part D plan sponsor.

The request generally must be filed within 65 calendar days from the date of the coverage-determination notice, subject to Medicare rules concerning good cause for late filing. The enrollee, prescriber or representative may generally request the redetermination.

For a redetermination, the plan must generally decide:

Standard request — no later than 7 calendar days

Expedited request — no later than 72 hours

and sooner when the enrollee’s health requires.

Notice how these deadlines differ from the initial coverage determination.

Part D Coverage Determination vs. Redetermination

StageStandardExpedited
Initial benefit coverage determination72 hours24 hours
Exception coverage determination72 hours after supporting statement24 hours after supporting statement
Level 1 redetermination7 calendar days72 hours

Authorization teams should track the stage as well as the deadline. Otherwise a 72-hour redetermination can easily be confused with a 72-hour initial standard coverage determination.

Higher Levels of Medicare Part D Appeal

If the plan upholds the denial at redetermination, the Medicare Part D appeals framework can continue through additional levels when applicable. The pathway can include:

Coverage Determination

↓

Level 1 — Redetermination by the Part D Plan

↓

Level 2 — Reconsideration by the Independent Review Entity

↓

Level 3 — Administrative Law Judge/OMHA review when applicable requirements are met

↓

Level 4 — Medicare Appeals Council review

↓

Level 5 — Federal District Court judicial review when applicable requirements are met

Prescribers Have an Important Role in Part D Appeals

A prescribing physician or other prescriber can request certain Part D coverage determinations and appeals on behalf of the enrollee without necessarily becoming the patient’s formally appointed representative for those functions. CMS also provides standardized forms for:

  • Medicare Prescription Drug Coverage Determinations
  • Medicare Prescription Drug Redeterminations
  • Reconsideration of Prescription Drug Denials
  • Appointment of Representative

Common Reasons Medicare Part D PA Requests Fail

The Wrong Benefit Was Used

The medication should have been handled under another Medicare benefit.

Prevention: Verify Part B versus Part D responsibility first.

The Drug Is Non-Formulary

Staff submits a routine PA instead of recognizing that a formulary exception may be needed.

Prevention: Check formulary status before selecting the request type.

Step Therapy Was Not Addressed

The request does not document required previous therapy.

Prevention: Provide detailed treatment history.

Quantity Limit Was Overlooked

The medication is covered, but the requested amount exceeds the plan limit.

Prevention: Verify quantity restrictions.

Diagnosis Is Missing or Unclear

The plan cannot determine whether the indication meets criteria.

Prevention: Submit diagnosis and supporting clinical documentation.

Treatment Failure Is Poorly Documented

The chart says “failed” without explaining the treatment course.

Prevention: Document medication, dose, duration, response and reason for discontinuation.

Supporting Statement Is Delayed

An exception request is opened, but the prescriber’s supporting statement is not sent promptly.

Prevention: Treat the supporting statement as part of the initial submission workflow.

Staff Waits for the Next Pharmacy Rejection

No one actively tracks the request.

Prevention: Maintain a centralized PA queue.

Medicare Part D Prior Authorization Tracking Fields

A structured authorization tracker can include:

FieldPurpose
PatientIdentifies beneficiary
Member IDMatches Part D coverage
Part D planIdentifies payer
DrugRequested medication
StrengthExact prescription
QuantityRequested amount
Days’ supplyPrescription duration
DiagnosisClinical indication
PrescriberOrdering clinician
Formulary statusCovered/non-formulary
TierCost-sharing tier
PAYes/No
Step therapyYes/No
Quantity limitYes/No
Request typePA/exception/etc.
Standard/expeditedDecision timeframe
Submission timeDeadline calculation
Supporting statementSent/received
Reference numberCase tracking
StatusCurrent stage
Decision deadlineFollow-up control
DeterminationApproved/denied
Authorization datesCoverage period
AppealRequired/not required
Pharmacy notifiedClosed-loop communication
Patient notifiedPatient follow-up

Build a Part D Authorization Work Queue by Deadline

Because Medicare Part D has defined decision timeframes, practices should prioritize requests accordingly. A practical queue can separate:

Expedited Initial Requests

Highest monitoring priority because the applicable decision window may be 24 hours.

Standard Initial Requests

Track against the applicable 72-hour window.

Exception Requests Awaiting Supporting Statement

These deserve immediate attention because the applicable decision clock for an exception does not begin until the prescriber’s supporting statement is received.

Denied Requests

Route to clinical review for appeal or alternative treatment decisions.

Transition-Fill Patients

Track the date the temporary supply is expected to run out. This is much safer than sorting the work queue only by the date staff received the request.

Part D Prior Authorization KPIs

Practices handling substantial medication volume should monitor performance.

KPIWhat It Measures
First-pass approval rateInitial submission quality
Missing-information rateDocumentation gaps
PA turnaroundWorkflow efficiency
Expedited request volumeUrgent medication access
Step-therapy exception rateFormulary-management impact
Quantity-limit exception rateDose/quantity restrictions
Appeal rateInitial adverse determinations
Appeal overturn rateStrength of reconsideration cases
Transition-fill resolution rateContinuity-of-therapy performance
Pharmacy repeat-rejection rateClosed-loop failure
Abandoned prescription ratePotential access problem
Prescriber response timeInternal workflow speed

A Practical Medicare Part D PA Workflow

You need to use this sequence:

1. Identify the patient’s Part D plan

↓

2. Verify active drug coverage

↓

3. Determine whether the medication belongs under Part D

↓

4. Check formulary status

↓

5. Identify PA, step therapy or quantity limits

↓

6. Review the plan’s drug-specific criteria

↓

7. Determine whether routine PA or an exception is needed

↓

8. Collect patient-specific clinical evidence

↓

9. Obtain the prescriber’s supporting statement when required

↓

10. Submit through the plan’s accepted pathway

↓

11. Record the submission date and applicable deadline

↓

12. Monitor until a determination is issued

↓

13. Communicate with the pharmacy and patient

↓

14. If denied, review the reason and determine the appropriate appeal or treatment pathway

↓

15. Track approval expiration and future refills

Preparing for Electronic Medicare Part D Prior Authorization

Part D authorization is also moving toward greater electronic interoperability. Medicare currently advises beneficiaries that beginning January 1, 2027, plans may be able to process prior authorization requests electronically and patients may be able to access decisions through patient portals. For provider organizations, that makes structured clinical information increasingly important. Data such as:

  • Diagnosis
  • Drug
  • Dose
  • Treatment history
  • Previous therapy
  • Contraindications
  • Laboratory findings
  • Clinical rationale

should be documented in ways that can be retrieved efficiently instead of reconstructed manually every time an authorization is required.

Medicare Part D Pre-Submission Checklist

Before submitting a request, verify:

  • Correct patient
  • Active Part D coverage
  • Correct Part D plan
  • Correct medication
  • Correct strength
  • Correct dosage form
  • Correct dose
  • Correct quantity
  • Correct days’ supply
  • Correct diagnosis
  • Formulary status
  • Formulary tier
  • Prior-authorization requirement
  • Step-therapy requirement
  • Quantity limit
  • Previous medications
  • Treatment duration
  • Treatment response
  • Adverse effects
  • Contraindications
  • Relevant laboratory/test information
  • Appropriate request type
  • Supporting statement when required
  • Standard versus expedited status
  • Correct submission pathway
  • Confirmation/reference number
  • Applicable decision deadline

Frequently Asked Questions About Medicare Part D Prior Authorization

What is Medicare Part D prior authorization?

It is a coverage requirement used by Medicare Part D plans for certain prescription drugs. The patient and/or prescriber must obtain approval based on the plan’s requirements before the plan will cover the medication.

Does every Medicare Part D plan use the same prior authorization list?

No, part D plans maintain their own formularies and coverage rules within Medicare requirements. Providers should check the patient’s current plan.

Can a drug be on the formulary and still require prior authorization?

Yes, a formulary drug may still have prior authorization, step therapy, quantity limits or other applicable utilization-management requirements.

How long does a standard Medicare Part D prior authorization decision take?

For an initial standard benefit coverage determination that does not involve an exception, CMS generally requires a decision within 72 hours after the plan receives the request.

How long does an expedited Part D decision take?

For an accepted expedited benefit coverage determination, the plan generally must decide within 24 hours.

When does the clock begin for an exception request?

For a benefit request involving an exception, the applicable 72-hour or 24-hour adjudication timeframe begins once the Part D plan receives the prescriber’s supporting statement.

Who can request a Part D coverage determination?

The enrollee, the enrollee’s prescriber or the enrollee’s representative can request a standard or expedited coverage determination.

What is a formulary exception?

It is a type of coverage determination requesting coverage for a non-formulary Part D drug or asking the plan to waive a formulary utilization-management requirement such as prior authorization, step therapy or a quantity limit.

What is a tiering exception?

A tiering exception asks the plan, when applicable under Part D rules, to cover a non-preferred formulary drug using the cost-sharing terms associated with a preferred tier.

Can a patient request an exception to step therapy?

Yes, the patient or prescriber can request an exception, supported by the prescriber’s medical explanation of why the required alternative would be less effective or would cause adverse effects.

Can a patient request an exception to a quantity limit?

Yes, an exception may be requested when the prescriber believes the plan’s quantity restriction is not medically appropriate for the patient’s condition.

What happens after a Part D PA denial?

The adverse coverage determination should explain the patient’s appeal rights. The first appeal level is generally a redetermination by the Part D plan.

How long does a Part D redetermination take?

The plan generally must issue its decision within seven calendar days for a standard redetermination or within 72 hours for an expedited redetermination, and sooner when required by the enrollee’s health.

How long does the patient have to request a redetermination?

CMS currently states that a redetermination request generally must be filed within 65 calendar days from the date of the coverage-determination notice, subject to applicable good-cause rules.

Related Prior Authorization Guides

Need Expert Help With Medicare Part D Prior Authorization Guidelines 2027: What Every Your Practice Should Know About Precertification and Payer Compliance?

Let our certified billing specialists handle coding, claims and denials so you can focus on patient care. Talk to our team today.